Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

80
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
80

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol-related liver disease in human immunodeficiency virus.

World journal of virology·2026
Same author

Editorial: The MASLD spectrum: an emerging epidemic of cardiometabolic and extra-hepatic dimensions.

Frontiers in epidemiology·2026
Same author

A Review of Therapies for Primary Biliary Cholangitis.

Gastroenterology & hepatology·2026
Same author

Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction-associated steatotic liver disease.

Frontiers in epidemiology·2026
Same author

Evolving spectrum and outcomes of infective endocarditis in North India: A comparative analysis between people who inject drugs and those who do not.

Indian heart journal·2026
Same author

Severe Hypertriglyceridemia With Lipemia-Induced Analytical Interference: Diagnostic Challenges in a Chylomicronemia Phenotype.

JACC. Case reports·2026

Related Experiment Video

Updated: Jun 8, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.1K

Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease.

Anmol Singh1, Aalam Sohal2, Akash Batta3

  • 1Department of Medicine, Tristar Centennial Medical Center, Nashville, TN 37203, United States.

World Journal of Gastroenterology
|November 4, 2024
PubMed
Summary

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over a third of the global population. Combining non-invasive biomarkers improves MAFLD diagnosis, especially for advanced liver fibrosis.

Keywords:
Enhanced liver fibrosisFibrosis-4 indexMagnetic resonance elastographyMetabolic-associated fatty liver diseaseNon-invasive tests

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

788
Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.2K

Related Experiment Videos

Last Updated: Jun 8, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.1K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

788
Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.2K

Area of Science:

  • Hepatology
  • Metabolic Disorders
  • Diagnostic Medicine

Background:

  • Metabolic dysfunction-associated fatty liver disease (MAFLD) prevalence is rising globally, impacting over 33% of the population.
  • Diagnosing advanced liver fibrosis in MAFLD is challenging due to liver biopsy limitations.
  • Non-invasive tests are vital for early MAFLD detection and management.

Approach:

  • The fibrosis-4 index (Fib-4) is a recommended first-line screening tool for liver fibrosis.
  • Advanced imaging like elastography offers accuracy but faces cost and availability constraints.
  • Combining biomarkers, such as enhanced liver fibrosis (ELF) score and FibroScan-AST, improves diagnostic precision.

Key Points:

  • Fib-4 index serves as an initial screening method for liver fibrosis.
  • Advanced imaging techniques provide accurate but less accessible diagnostic options.
  • Combining multiple biomarkers enhances the accuracy of MAFLD and fibrosis staging.

Conclusions:

  • Future MAFLD diagnosis relies on integrating multiple non-invasive biomarkers.
  • Combined biomarker approaches offer improved accuracy for stratifying intermediate and high-risk patients.
  • Enhanced diagnostic strategies are crucial for managing the growing MAFLD epidemic.